Current Report Filing (8-k)
August 23 2016 - 4:31PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 17, 2016
BIOSOLAR,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-54819
|
|
20-4754291
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
27936
Lost Canyon Road, Suite 202, Santa Clarita, CA 91387
(Address
of principal executive offices and Zip Code)
Registrant's
telephone number, including area code:
(661) 251-0001
Copies
to:
Gregory
Sichenzia, Esq.
Marcelle
S. Balcombe, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway, 32
nd
Floor
New
York, New York 10006
Phone:
(212) 930-9700
Fax:
(212) 930-9725
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
1.01 Entry into a Material Definitive Agreement.
On
August 23, 2016, BioSolar, Inc. (the “Company”) announced that the Company entered into a research agreement (the
“Agreement”), effective August 17, 2016, with North Carolina Agricultural and Technical State University, a constituent
member of the University of North Carolina system (the “University”).
Pursuant
to the terms of the Agreement, the Company shall sponsor the University’s project which shall include the research, testing
and evaluation of a proposal (the “Project”). Total costs to the Company are not to exceed the sum of $123,993. The
University was to commence performance of the Project promptly after August 16, 2016 and the Agreement shall continue for the
contract period, which is from September 12, 2016 through September 11, 2017. The Agreement may be extended upon mutual agreement
by the parties and may be terminated due to the inability of the principal investigator to continue the Project,
and a mutually acceptable substitute is not available, or upon thirty (30) days prior written notice by either party to the other.
A
copy of the press release is included hereto as Exhibit 99.1.
Item
1.02 Termination of a Material Definitive Agreement.
On
August 17, 2016, the Company notified the University of California-Santa Barbara (“UCSB”) of its intent to terminate
the research agreement, dated June 17, 2014, by and between the Company and UCSB, as amended January 29, 2016 (the “UCSB
Agreement”). The UCSB Agreement provided that the Company would sponsor a UCSB research project. The UCSB Agreement was
amended on January 29, 2016 to extend the term of the UCSB Agreement to June 30, 2017. Pursuant to the terms of the UCSB Agreement,
the Company provided sixty (60) days written notice for an intended early termination date of October 17, 2016. The Company will
not incur any early termination penalties.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
Exhibit Number
|
|
Description
|
99.1
|
|
Press
Release dated August 23, 2016.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BIOSOLAR,
INC.
|
|
|
Date:
August 23, 2016
|
/s/
David Lee
|
|
David
Lee
|
|
Chief
Executive Officer
|
3